Literature DB >> 15042664

Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study.

Jane Warwick1, Lazlo Tabàr, Bedrich Vitak, Stephen W Duffy.   

Abstract

BACKGROUND: Tumor size, lymph node status, and histologic grade are reported to be important predictors of survival in the first 5 years after the diagnosis of invasive breast carcinoma. However, to the authors' knowledge, the effect of these factors in the longer term (>10 years after diagnosis) is not yet clear.
METHODS: It is now >20 years since the Swedish Two-County Trial of breast carcinoma screening with mammography was instigated and long-term follow-up is now available to December 1998. In the current study, the authors analyzed the effects of tumor size, lymph node status, and tumor grade on survival to death from breast carcinoma using Cox regression and frailty models that allow the baseline hazard and/or effect of a covariate to vary with time.
RESULTS: The effects of tumor size, lymph node status, and tumor grade were shown to progressively diminish with time from diagnosis. The Cox regression model with time-varying coefficients and a dampening parameter then was fitted to allow for the attenuation of prognostic effects; tumor size, lymph node status, and tumor grade were all found to be highly significant (P<0.001).
CONCLUSIONS: The results of the current study suggest that long-term survival in women with invasive breast carcinoma could be modelled satisfactorily using either frailty models or Cox regression models with time-varying coefficients. The results also suggest that the value of tumor grade, lymph node status, and tumor size at the time of diagnosis have a lasting influence on subsequent survival, albeit attenuated in later years. The long-term effects of these prognostic factors may explain the fact that the impact of mass screening programs on breast carcinoma mortality rates is still apparent many years later. Copyright 2004 American Cancer Society.

Entities:  

Mesh:

Year:  2004        PMID: 15042664     DOI: 10.1002/cncr.20140

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

1.  Clinical features and first degree relative breast cancer, their correlation with histological tumor grade: a 5-year retrospective case study of breast cancer in Mizoram, India.

Authors:  Doris Zodinpuii; Jeremy Lalrinsanga Pautu; Bawitlung Zothankima; Lalawmpuii Pachuau; Nachimuthu Senthil Kumar
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-25       Impact factor: 4.223

2.  Evidence for improved survival in postsymptomatic stem cell-transplanted patients with Krabbe's disease.

Authors:  Thomas J Langan; Amy L Barcykowski; Jonathan Dare; Erin C Pannullo; Leah Muscarella; Randy L Carter
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.

Authors:  Neha Bhooshan; Maryellen L Giger; Sanaz A Jansen; Hui Li; Li Lan; Gillian M Newstead
Journal:  Radiology       Date:  2010-02-01       Impact factor: 11.105

4.  Computerized three-class classification of MRI-based prognostic markers for breast cancer.

Authors:  Neha Bhooshan; Maryellen Giger; Darrin Edwards; Yading Yuan; Sanaz Jansen; Hui Li; Li Lan; Husain Sattar; Gillian Newstead
Journal:  Phys Med Biol       Date:  2011-08-22       Impact factor: 3.609

5.  Effect of prior radiation on stage, differentiation, and survival in bladder cancer.

Authors:  Syed M Alam; Lynn Chollet-Hinton; Jeffrey Thompson; Jeffrey M Holzbeierlein
Journal:  World J Urol       Date:  2022-01-06       Impact factor: 4.226

6.  Time-varying effects of prognostic factors associated with disease-free survival in breast cancer.

Authors:  Loki Natarajan; Minya Pu; Barbara A Parker; Cynthia A Thomson; Bette J Caan; Shirley W Flatt; Lisa Madlensky; Richard A Hajek; Wael K Al-Delaimy; Nazmus Saquib; Ellen B Gold; John P Pierce
Journal:  Am J Epidemiol       Date:  2009-04-29       Impact factor: 4.897

7.  Time-varying effects of prognostic factors associated with long-term survival in breast cancer.

Authors:  Minlu Zhang; Peng Peng; Kai Gu; Hui Cai; Guoyou Qin; Xiao Ou Shu; Pingping Bao
Journal:  Endocr Relat Cancer       Date:  2018-02-22       Impact factor: 5.678

8.  Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk.

Authors:  Solange Torchia Carvalho; Monica Maria Stiepcich; José Humberto Fregnani; Sueli Nonogaki; Rafael Rocha; Fernando Augusto Soares
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 9.  Breast cancer prognostic classification in the molecular era: the role of histological grade.

Authors:  Emad A Rakha; Jorge S Reis-Filho; Frederick Baehner; David J Dabbs; Thomas Decker; Vincenzo Eusebi; Stephen B Fox; Shu Ichihara; Jocelyne Jacquemier; Sunil R Lakhani; José Palacios; Andrea L Richardson; Stuart J Schnitt; Fernando C Schmitt; Puay-Hoon Tan; Gary M Tse; Sunil Badve; Ian O Ellis
Journal:  Breast Cancer Res       Date:  2010-07-30       Impact factor: 6.466

10.  Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.

Authors:  Huma Dar; Annelie Johansson; Anna Nordenskjöld; Adina Iftimi; Christina Yau; Gizeh Perez-Tenorio; Christopher Benz; Bo Nordenskjöld; Olle Stål; Laura J Esserman; Tommy Fornander; Linda S Lindström
Journal:  JAMA Netw Open       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.